Dysregulation of BCL-2 family proteins by leukaemia fusion genes
Details
Publication Year 2017-09-01,Volume 292,Issue #35,Page 14325-14333
Journal Title
Journal of Biological Chemistry
Publication Type
Journal Article
Abstract
The genomic lesions that characterise acute lymphoblastic leukaemia in childhood include recurrent translocations that result in the expression of fusion proteins. These translocations typically involve the rearrangement of genes encoding tyrosine kinases, including receptor tyrosine kinase, cytokine receptors and transcription factors. These confer phenotypic changes that are the hallmarks of malignant transformation, including unrestricted proliferation and a relative resistance to apoptosis. In this review, we explore the molecular mechanisms that link these fusions to the control of cell death. More specifically, we look at the regulation of the BCL-2 family of proteins by these fusion genes to prevent the activation of apoptotic effectors, BAX and BAX, and promote cell survival.
Publisher
ASBMB
Research Division(s)
Cancer And Haematology
PubMed ID
28717011
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2017-08-30 02:22:42
Last Modified: 2018-05-07 03:02:30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙